Cargando…
Cardiac events after using clarithromycin for anti-Helicobacter pylori therapy in patients with coronary artery disease
Clarithromycin is an antibiotic commonly used to treat Helicobacter pylori infections. The US Food and Drug Administration (FDA) advises caution before prescribing clarithromycin to patients with cardiac diseases. This study aimed to evaluate cardiac events after anti-H pylori treatment in patients...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637519/ https://www.ncbi.nlm.nih.gov/pubmed/37960819 http://dx.doi.org/10.1097/MD.0000000000035922 |